Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Pharming Group N.V. - Filing #1859781

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
23,078,000 USD
44,094,000 USD
Revenue
198,871,000 USD
212,174,000 USD
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
37,842,000 USD
83,626,000 USD
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
21,305,000 USD
15,629,000 USD
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
27,947,000 USD
60,686,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.